COVID-19 in people with diabetes: understanding the reasons for worse outcomes

M Apicella, MC Campopiano, M Mantuano… - The lancet Diabetes & …, 2020 - thelancet.com
Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …

COVID-19–induced new-onset diabetes: trends and technologies

AA Metwally, P Mehta, BS Johnson, A Nagarjuna… - Diabetes, 2021 - Am Diabetes Assoc
The coronavirus disease 2019 (COVID-19) global pandemic continues to spread worldwide
with approximately 216 million confirmed cases and 4.49 million deaths to date. Intensive …

Diabetes in sub-saharan africa

JCN Mbanya, AA Motala, E Sobngwi, FK Assah… - The lancet, 2010 - thelancet.com
Summary In Sub-Saharan Africa, prevalence and burden of type 2 diabetes are rising
quickly. Rapid uncontrolled urbanisation and major changes in lifestyle could be driving this …

A sub-Saharan African perspective of diabetes

GV Gill, JC Mbanya, KL Ramaiya, S Tesfaye - Diabetologia, 2009 - Springer
Diabetes mellitus is an important and increasing cause of morbidity and mortality in sub-
Saharan Africa. Accurate epidemiological studies are often logistically and financially …

Syndromes of ketosis-prone diabetes mellitus

A Balasubramanyam, R Nalini, CS Hampe… - Endocrine …, 2008 - academic.oup.com
Ketosis-prone diabetes (KPD) is a widespread, emerging, heterogeneous syndrome
characterized by patients who present with diabetic ketoacidosis or unprovoked ketosis but …

PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study

J Delyon, L Biard, M Renaud, M Resche-Rigon… - The Lancet …, 2022 - thelancet.com
Background Although the treatment of iatrogenic and HIV-related Kaposi sarcoma is well
defined and mostly based on restoring immune function, the treatment of classic and …

Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review

D Kibirige, W Lumu, AG Jones, L Smeeth… - Clinical diabetes and …, 2019 - Springer
Background Globally, the burden of diabetes mellitus has increased to epidemic
proportions. Estimates from the International Diabetes Federation predict that the greatest …

Infections and diabetes: Risks and mitigation with reference to India

R Unnikrishnan, A Misra - … & Metabolic Syndrome: Clinical Research & …, 2020 - Elsevier
Background and aims The link between diabetes and increased risk of infectious disease
has long been recognized, but has re-entered sharp focus following the COVID-19 …

Pathophysiology of type 2 diabetes in sub-Saharan Africans

JH Goedecke, AE Mendham - Diabetologia, 2022 - Springer
Abstract Sub-Saharan Africa (SSA) is the region with the highest projected rates of increase
in type 2 diabetes (129% by 2045), which will exacerbate the already high prevalence of …

Human herpesvirus 8–related Castleman disease in the absence of HIV infection

A Dossier, V Meignin, C Fieschi… - Clinical infectious …, 2013 - academic.oup.com
Background. Castleman disease (CD) in the context of human immunodeficiency virus (HIV)
infection is well described. It is almost always multicentric (MCD) and linked to human …